An international group of cancer researchers led by the National Cancer Research Institute’s (NCRI’s) Cellular Molecular Pathology Initiative (CMPath) has published guidance to address the variability in how pathology (the […]
Lessons learned from a new survey about what motivates and retains patients in rare disease trials could have much wider applications in other clinical trials, according to those who conducted […]
“The FDA doesn’t call to ask if it’s a good time for an inspection,” Neala Lane, Associate Director, Quality Improvement Office at Indiana University told attendees of ACRP’s Virtual […]
Moffitt Cancer Center is among more than 75 sites participating in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community […]
As clinical research professionals, we understand the value of patient-donated data. Clinical trials can be time-consuming and sometimes onerous for patients, so we owe it to patients to use their […]